Investigational drug restores calcium levels in rare genetic disorder

An investigational drug, encaleret, restored calcium levels in people with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic disorder marked by an imbalance of calcium in the blood and urine, as well as abnormally low levels of parathyroid hormone, which regulates blood calcium levels.

Study shows lasting COVID-19 symptoms lead to economic struggles for US families

Study reveals that persistent COVID-19 symptoms and severe infections significantly impact the economic conditions of US families, with low-income households being more vulnerable to financial

December 14, 2023

AbbVie inks deal for Medincell’s long-acting injectable platform worth up to $1.9B

AbbVie is betting more than $1.9 billion on a French biotech’s long-acting injectable technology. The deal gives Medincell $35 million upfront and up to $1.9

April 17, 2024

Coronary Heart Disease by Age 45 Linked With Later Dementia

Younger onset age of coronary heart disease was tied to higher risks of incident all-cause dementia, Alzheimer’s disease, and vascular dementia, a large prospective cohort

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.